Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drais Pharmaceuticals Inc.

www.draispharma.com

Latest From Drais Pharmaceuticals Inc.

RSV deal spearheads Astellas's new push into vaccines

Astellas is signaling its strategic intention to move more deeply into vaccines through a risk-sharing and licensing alliance with two firms for a product against respiratory syncytial virus (RSV).

Infectious Diseases Respiratory

To Meet Demand, Forma Aims To Boost Discovery Supply

Forma Therapeutics has already convinced several big industry partners its discovery engine will yield oncology candidates in emerging areas of research. Now it wants to find academic groups to help feed its engine, all while the resurgent biotech IPO market might make its unusual structure superfluous.

BioPharmaceutical United States

Forma To Rev Its Discovery Engine For Deubiquitination

In a new collaboration with Cancer Research Technology, drug-discovery firm Forma Therapeutics adds another area of cancer biology – and another unusual deal structure – to its panoply of partnerships.

BioPharmaceutical United Kingdom

Recent Financings Of Private Companies, June 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies in the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Drais Pharmaceuticals Inc.
  • Senior Management
  • Donna L Tempel, PhD, Pres. & CEO
    Robert E Desjardins, MD, CSO
  • Contact Info
  • Drais Pharmaceuticals Inc.
    Phone: (908) 895-1200
    520 US Hwy 22
    Ste. 201
    Bridgewater, NJ 08807
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register